CoChat

Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study

Ramezani Tehrani, Fahimeh, Minooee, Sonia, Azizi, Fereidoun · 2014 · European Journal of Endocrinology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Objective: Insulin resistance (IR) and metabolic disorders are common in polycystic ovary syndrome (PCOS). However, it is still not clear which adiposity marker could precisely predict metabolic syndrome (MetS) in women with PCOS and whether these indexes are different in normo-ovulatory non-hirsute women. Design: A case–control study was conducted on a total of 175 Iranian subjects with PCOS and 525 normal control subjects, aged 18–45 years. Methods: Waist circumference (WC), BMI, waist-to-hip ratio, lipid accumulation product (LAP) index, and visceral adiposity index (VAI) were examined and the homeostasis model assessment index was calculated. MetS was defined according to the joint interim statement. The receiver operating characteristic curves were used to evaluate the extent to which measures of adiposity can predict IR and MetS risk. Results: LAP index and VAI are two indicators (sensitivity and PPV of 70% (LAP index) and 60% (VAI), and 80% (LAP index) and 83% (VAI) respectively) that best predict IR in women with PCOS. Among healthy women, the LAP index and WC were better markers (sensitivity and PPV of 78% (LAP index) and 75% (VAI), and 82% (LAP index) and 81% (VAI) respectively). The two most reliable indicators for prediction of MetS among PCOS and normal women were the WC and VAI (sensitivity and PPV of 83% (WC) and 81% (VAI), and 97% (WC) and 95% (VAI) respectively) and the VAI and LAP index (sensitivity and PPV of 88% (VAI) and 83% (LAP index), and 98% (VAI) and 98% (LAP index) respectively) respectively. Conclusions: While the appropriate adiposity indicators and their optimum cutoff values vary in women with PCOS, compared with the normal control subjects, the LAP index is an easily obtainable index that might be useful for screening of cardiometabolic complications among both groups.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-14-0094

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 57 · Cited by 51

Research works printed but not linked: 4

  1. 2013, JOURNAL OF OBESITY, 2013, 269038
  2. 2013, DIABETES METABOLIC SYNDROME AND OBESITY TARGETS AND THERAPY, 6, 403
  3. 2013, European journal of obstetrics, gynecology, and reproductive biology, 174, 100
  4. 2011, INTERNATIONAL JOURNAL OF HYPERTENSION, 2011, 931402

Metadata

Authors
Ramezani Tehrani, F., Minooee, S., & Azizi, F.
Affiliations
Research Institute for Endocrine Sciences (IR)
Venue
European Journal of Endocrinology
Published
2014-08
Volume
171
Issue
2
Pages
199-207
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2156169093
Cited by
51
References
57
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 2
FWCI
3.23
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchOnline at James Cook University (James Cook University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
polycystic ovary syndrome, adiposity indices, metabolic syndrome, insulin resistance, lipid accumulation product, visceral adiposity index, waist circumference, waist-to-hip ratio, body mass index, Iranian women
MeSH terms
Adult, Female, Humans, Insulin Resistance, Iran, Lipids, Middle Aged, Polycystic Ovary Syndrome, Body Mass Index, Case-Control Studies, Metabolic Syndrome, Waist-Hip Ratio, Adiposity, Waist Circumference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. https://app.cochat.ai/papers/10.1530/eje-14-0094
The paper
Ramezani Tehrani, F., Minooee, S., & Azizi, F. (2014). Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. European Journal of Endocrinology. https://doi.org/10.1530/eje-14-0094

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.